W
W. H. Birkenhäger
Researcher at Katholieke Universiteit Leuven
Publications - 122
Citations - 4867
W. H. Birkenhäger is an academic researcher from Katholieke Universiteit Leuven. The author has contributed to research in topics: Blood pressure & Essential hypertension. The author has an hindex of 28, co-authored 122 publications receiving 4814 citations. Previous affiliations of W. H. Birkenhäger include Erasmus University Rotterdam & Ruijin Hospital.
Papers
More filters
Journal ArticleDOI
Mortality and morbidity results from the european working party on high blood pressure in the elderly trial
Antoon Amery,Brixko P,Denis Clement,A.F. De Schaepdryver,Robert Fagard,J. Forte,Henry Jf,Gastone Leonetti,Kevin O'Malley,T. Strasser,W. H. Birkenhäger,Christopher J. Bulpitt,Deruyttere M,Colin T. Dollery,Françoise Forette,R. Hamdy,Jozef Victor Joossens,P. Lund-Johansen,J C Petrie,J. Tuomilehto,Bryan Williams +20 more
TL;DR: In the patients randomised to active treatment there were 29 fewer cardiovascular events and 14 fewer cardiovascular deaths per 1000 patient years during the double-blind part of the trial.
Journal ArticleDOI
Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension
Jaakko Tuomilehto,Daiva Rastenyte,W. H. Birkenhäger,Lutgarde Thijs,Riitta Antikainen,Christopher J. Bulpitt,Astrid E. Fletcher,Françoise Forette,Adiv Goldhaber,Paolo Palatini,Cinzia Sarti,Robert Fagard +11 more
TL;DR: Antihypertensive treatment with the calcium-channel blocker nitrendipine reduced the risk of cardiovascular events in diabetic and nondiabetic patients and was compared with placebo in this post hoc analysis.
Journal ArticleDOI
Effects of Calcium-Channel Blockade in Older Patients with Diabetes and Systolic Hypertension
Jaakko Tuomilehto,Daiva Rastenyte,W. H. Birkenhäger,Lutgarde Thijs,Riitta Antikainen,Christopher J. Bulpitt,Astrid E. Fletcher,Françoise Forette,Adiv Goldhaber,Paolo Palatini,Cinzia Sarti,Robert Fagard +11 more
TL;DR: In this paper, the authors compared the outcome of treatment with nitrendipine in diabetic and nondiabetic patients, and reported that antihypertensive treatment with the calcium-channel blocker reduced the risk of cardiovascular events.
Journal ArticleDOI
Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60
A Amery,Brixko R,Denis Clement,A.F. De Schaepdryver,Robert Fagard,J. Forte,Henry Jf,Gastone Leonetti,Kevin O'Malley,T. Strasser,W. H. Birkenhäger,Christopher J. Bulpitt,Deruyttere M,Colin T. Dollery,Françoise Forette,R. Hamdy,Jozef Victor Joossens,P. Lund-Johansen,J C Petrie,J. Tuomilehto,Bryan Williams +20 more
TL;DR: Little or no benefit from treatment could be demonstrated in patients over the age of 80 years, the great majority of whom were women, and there was some evidence that treatment effect decreases with advancing age.
Journal Article
Influence of antihypertensive drug treatment on morbidity and mortality in patients over the age of 60 years. European Working Party on High blood pressure in the Elderly (EWPHE) results: sub-group analysis on entry stratification.
A Amery,W. H. Birkenhäger,Brixko P,Christopher J. Bulpitt,Denis Clement,de Leeuw P,De Plaen Jf,Deruyttere M,De Schaepdryver A,Colin T. Dollery +9 more
TL;DR: Although the event rates were greater for patients with previous cardiovascular events and patients over the age of 70 years, the percentage reduction in cardiovascular events was similar in these groups to those without complications and in patients between 60 and 69 years of age.